25-Feb-2021
The Conversation
The COVID-19 pandemic, and the race to make vaccines and other useful technologies more accessible to people around the world, has once again highlighted the tension between intellectual property rights and the promotion of public health.
29-Sep-2020
European Pharmaceutical Review
They have both emphasised the need for trade talks to mitigate medicine supply chain disruptions following Brexit.
14-Aug-2020
Nikkei Asian Review
Vietnam seeks to build on its new free trade agreement with the European Union to expand foreign investment in medical equipment and pharmaceuticals, with the government position the country as an alternative production base to China.
6-May-2020
The Independent
The US trade model is not only unpopular with the British public, but it will also make us more vulnerable to future pandemics.
2-Apr-2020
Hindustan Times
In order to halt the spread of the coronavirus pandemic (Covid-19) and to boost the public health care system and preparedness, India has taken several regulatory steps.
25-Mar-2020
Observatoire Tunisien de l’Economie
If the intellectual property provisions of the DCFTA are applied, this will have an impact on both the cost of patented medicines and undermine access to affordable medicines.
27-Jan-2020
Sunday Guardian Live
India and Indonesia are set to launch negotiations for a Comprehensive Economic Cooperation Agreement (CECA) to cover economic cooperation while trading in goods, services, and investments.
10-Dec-2019
Modern Health Care
A provision of the United States-Mexico-Canada Agreement on trade that would have guaranteed 10 years of market exclusivity for biologic drugs was removed.